NYSE American - Delayed Quote • USD
AIM ImmunoTech Inc. (AIM)
At close: 3:59 PM EDT
After hours: 5:52 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.12 | -0.12 | -0.45 | -0.45 |
Low Estimate | -0.12 | -0.12 | -0.45 | -0.45 |
High Estimate | -0.12 | -0.12 | -0.45 | -0.45 |
Year Ago EPS | -0.08 | -0.1 | -0.6 | -0.45 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 2 |
Avg. Estimate | -- | -- | 140k | 2.57M |
Low Estimate | -- | -- | 140k | 140k |
High Estimate | -- | -- | 140k | 5M |
Year Ago Sales | 49k | 20k | 202k | 140k |
Sales Growth (year/est) | -- | -- | -30.70% | 1,735.70% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.11 | -0.11 | -0.11 | -0.15 |
EPS Actual | -0.08 | -0.1 | -0.16 | -0.26 |
Difference | 0.03 | 0.01 | -0.05 | -0.11 |
Surprise % | 27.30% | 9.10% | -45.50% | -73.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.12 | -0.12 | -0.45 | -0.45 |
7 Days Ago | -0.12 | -0.12 | -0.45 | -0.45 |
30 Days Ago | -0.12 | -0.12 | -0.45 | -0.45 |
60 Days Ago | -0.12 | -0.12 | -0.45 | -0.45 |
90 Days Ago | -0.12 | -0.12 | -0.45 | -0.45 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | AIM | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -50.00% | -- | -- | 1.50% |
Next Qtr. | -20.00% | -- | -- | 11.40% |
Current Year | 25.00% | -- | -- | 5.20% |
Next Year | 0.00% | -- | -- | 13.40% |
Next 5 Years (per annum) | 25.00% | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Upgrade | Maxim Group: Hold to Buy | 10/10/2019 |
Related Tickers
ACET Adicet Bio, Inc.
1.8750
-10.71%
PPBT Purple Biotech Ltd
0.5127
+4.63%
COEP Coeptis Therapeutics Holdings, Inc.
0.3270
-2.39%
KPRX Kiora Pharmaceuticals, Inc.
0.5058
-12.72%
GRI GRI Bio, Inc.
0.4374
-2.13%
RNAZ TransCode Therapeutics, Inc.
0.4399
-4.35%
PBLA Panbela Therapeutics, Inc.
0.4101
-2.36%
VAXX Vaxxinity, Inc.
0.1326
-33.70%
MTEM Molecular Templates, Inc.
1.6400
+5.81%
MNPR Monopar Therapeutics Inc.
0.6570
+1.08%